参考文献

参考文献

1:  Onalan O, Lashevsky I, Hamad A, Crystal E.
Nonpharmacologic stroke prevention in atrial fibrillation.
Expert Rev Cardiovasc Ther 2005;3:619-33. 
 http://www.ncbi.nlm.nih.gov/pubmed/16076273 
  


 2: Aronow WS, Ahn C, Kronzon I, Gutstein H.

 

Incidence of new thromboembolic stroke in persons 62 years and

older with chronic atrial fibrillation treated with warfarin versus aspirin.
J Am Geriatr Soc 1999 47:366-8.

http://www.ncbi.nlm.nih.gov/pubmed/10078902


3: Harper P, Young L, Merriman E Bleeding risk with dabigatran in the frail elderly.
N Engl J Med 2012;366:864-6.
http://www.ncbi.nlm.nih.gov/pubmed/22375994 
4: Oluseun Alli, Shepal Doshi, Saibal Kar, et al. Quality of Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Non-valvular Atrial Fibrillation

6: Weerasooriya R, Khairy P, Litalien J, et al.
Catheter Ablation for Atrial Fibrillation
Are Results Maintained at 5 Years of Follow-Up?
J Am Coll Cardiol 2011;57:160-6.

http://www.ncbi.nlm.nih.gov/pubmed/21211687

 
7: Reddy VY et al. Percutaneous left atrial appendage closure vs Warfarin for atrial fibrillation JAMA 2014;312:1988-89.
８: Ohtsuka T, Ninomiya M, Nonaka T, Hisagi M, Ota T, Mizutani T.
Thoracoscopic Stand-alone Left Atrial Appendectomy for
Thromboembolism Prevention in Non-valvular Atrial Fibrillation
 


 

 
  
Page top